Improved Clinical Outcome after Acute Basilar Artery Occlusion since the Introduction of Endovascular Thrombectomy Devices

Background: Tenecteplase (TNK) is a genetically modified variant of alteplase with greater fibrin specificity and longer half-life than alteplase. The recent Tenecteplase versus Alteplase before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK) trial demonstrated that increased reperfusion with TNK compared to alteplase prior to endovascular thrombectomy (EVT) in large vessel occlusion ischaemic strokes. However, only 6 patients with basilar artery occlusion (BAO) were included. We aimed to investigate the efficacy of TNK versus alteplase before EVT in patients with basilar artery occlusion (BAO). Methods: Clinical and procedural data of consecutive BAO diagnosed on CT Angiography or MR Angiography from the multisite international Basilar Artery Treatment and MANagement (BATMAN) collaboration were retrospectively analysed. The primary outcome was reperfusion of greater than 50% of the involved ischemic territory or absence of retrievable thrombus at the time of the initial angiographic assessment. Results: We included 119 BAO patients treated with intravenous thrombolysis prior to EVT; mean age 68 (SD 14), median NIHSS 16 (IQR 7-32). Eleven patients were treated with TNK (0.25mg/kg or 0.4mg/kg) and 108 with alteplase (0.9mg/kg). Overall, 113 patients had catheter angiography or early repeat imaging after thrombolysis. Reperfusion of greater than 50% of the ischemic territory or absence of retrievable thrombus occurred in 4/11 (36%) of patients treated with TNK vs 8/102 (8%) treated with alteplase (p=0.02). Onset-to-needle time did not differ between the two groups (p=0.4). Needle-to-groin-puncture time was 61 (IQR 33-100) mins in patients reperfused with TNK vs 111 (IQR 86-198) mins in patients reperfused with alteplase (p=0.048). Overall, the rate of symptomatic haemorrhage was 3/119 (2.5%). No differences were found in the rate of symptomatic intracranial haemorrhage (p=0.3) between the two thrombolytic agents. Conclusions: Despite shorter needle-to-groin-puncture times, tenecteplase was associated with an increased rate of reperfusion in comparison with alteplase before EVT in BAO. Randomized controlled trials to compare tenecteplase with alteplase in BAO patients before endovascular thrombectomy are warranted.

Download Full-text

Outcomes of Endovascular Thrombectomy for Basilar Artery Occlusion

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ◽

10.1017/cjn.2020.51 ◽

2020 ◽

Vol 47 (4) ◽

pp. 479-485

Author(s):

Christopher R. Pasarikovski ◽

Houman Khosravani ◽

Leodante da Costa ◽

Chinthaka Heyn ◽

Stefano M. Priola ◽

...

Keyword(s):

Computed Tomography ◽

Functional Outcome ◽

Basilar Artery ◽

Treatment Time ◽

Intravenous Thrombolysis ◽

Artery Occlusion ◽

Posterior Circulation ◽

Basilar Artery Occlusion ◽

Related Complication ◽

Endovascular Thrombectomy

ABSTRACT:Background and Purpose:Large prospective observational studies have cast doubt on the common assumption that endovascular thrombectomy (EVT) is superior to intravenous thrombolysis for patients with acute basilar artery occlusion (BAO). The purpose of this study was to retrospectively review our experience for patients with BAO undergoing EVT with modern endovascular devices.Methods:All consecutive patients undergoing EVT with either a second-generation stent retriever or direct aspiration thrombectomy for BAO at our regional stroke center from January 1, 2013 to March 1, 2019 were included. The primary outcome measure was functional outcome at 1 month using the modified Rankin Scale (mRS) score. Multivariable logistic regression was used to assess the association between patient characteristics and dichotomized mRS.Results:A total of 43 consecutive patients underwent EVT for BAO. The average age was 67 years with 61% male patients. Overall, 37% (16/43) of patients achieved good functional outcome. Successful reperfusion was achieved in 72% (31/43) of cases. The median (interquartile range) stroke onset to treatment time was 420 (270–639) minutes (7 hours) for all patients. The procedure-related complication rate was 9% (4/43). On multivariate analysis, posterior circulation Alberta stroke program early computed tomography score and Basilar Artery on Computed Tomography Angiography score were associated with improved functional outcome.Conclusion:EVT appears to be safe and feasible in patients with BAO. Our finding that time to treatment and successful reperfusion were not associated with improved outcome is likely due to including patients with established infarcts. Given the variability of collaterals in the posterior circulation, the paradigm of utilizing a tissue window may assist in patient selection for EVT. Magnetic resonance imaging may be a reasonable option to determine the extent of ischemia in certain situations.

Download Full-text

Erratum. Mechanical thrombectomy in basilar artery occlusion: influence of reperfusion on clinical outcome and impact of the first-line strategy (ADAPT vs stent retriever)

Journal of Neurosurgery ◽

10.3171/2017.7.jns171043a ◽

2018 ◽

Vol 129 (6) ◽

pp. 1649 ◽

Cited By ~ 6

Author(s):

Benjamin Gory ◽

Bertrand Lapergue

Keyword(s):

Clinical Outcome ◽

Basilar Artery ◽

Mechanical Thrombectomy ◽

Artery Occlusion ◽

Stent Retriever ◽

Basilar Artery Occlusion ◽

First Line

Download Full-text

Initial factors affecting the clinical outcome after successful recanalization via MR-based mechanical thrombectomy in patients with acute ischemic stroke due to basilar artery occlusion

Journal of NeuroInterventional Surgery ◽

10.1136/neurintsurg-2015-011912 ◽

2015 ◽

Vol 8 (9) ◽

pp. 889-893 ◽

Cited By ~ 7

Author(s):

Seungnam Son ◽

Yong-Won Kim ◽

Min Kyun Oh ◽

Soo-Kyoung Kim ◽

Ki-Jong Park ◽

...

Keyword(s):

Ischemic Stroke ◽

Clinical Outcome ◽

Acute Ischemic Stroke ◽

Basilar Artery ◽

Mechanical Thrombectomy ◽

Artery Occlusion ◽

Basilar Artery Occlusion ◽

Nihss Score ◽

Diffusion Weighted Images ◽

Outcome Group

Background and purposeTo determine the initial factors, including patient characteristics, stroke etiology and severity, time factors, and imaging findings, that could affect the clinical outcome of patients with acute ischemic stroke (AIS) caused by basilar artery occlusion (BAO) where successful recanalization was achieved via mechanical thrombectomy.MethodsBetween March 2011 and December 2014, 35 patients with AIS caused by BAO received MRI/MR angiography-based mechanical thrombectomies, and recanalization was achieved with a Thrombolysis In Cerebral Infarction score of >2b. The patients were divided into a good outcome group (n=19), defined as those with a modified Rankin Scale (mRS) score of 0–2 at 3 months after stroke onset, and a poor outcome group (n=16), defined as a mRS score of 3–6. The differences between the groups were analyzed.ResultsInitial National Institutes of Health Stroke Scale (NIHSS) score (good vs poor: 17.9±8.9 vs 27.6±8.5, p=0.003), posterior circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS) based on initial diffusion-weighted images (DWI) (good vs poor: 7.8±1.6 vs 5.4±1.8, p=0.001), pc-ASPECTS based on contrast staining on the post-thrombectomy control CT (good vs poor: 9.2±1.5 vs 6.3±2.2, p<0.001), and presence of contrast staining in the brainstem on that CT (good vs poor: 15.8% vs 81.6%, p<0.001) were significantly different between the groups.ConclusionsPatients with AIS caused by BAO with a lower initial NIHSS score, fewer lesions on initial DWI, and less contrast staining on the post-thrombectomy control CT have higher probabilities of a good clinical outcome after successful recanalization via a mechanical thrombectomy.

Download Full-text

Predictors of Outcome After Endovascular Thrombectomy in Acute Basilar Artery Occlusion and the 6hr Time Window to Recanalization

Frontiers in Neurology ◽

10.3389/fneur.2019.00923 ◽

2019 ◽

Vol 10 ◽

Cited By ~ 1

Author(s):

Johannes Ravindren ◽

Marta Aguilar Pérez ◽

Victoria Hellstern ◽

Pervinder Bhogal ◽

Hansjörg Bäzner ◽

...

Keyword(s):

Basilar Artery ◽

Time Window ◽

Artery Occlusion ◽

Basilar Artery Occlusion ◽

Predictors Of Outcome ◽

Endovascular Thrombectomy

Download Full-text

Abstract 1122‐000068: Basilar Artery Occlusion Thrombectomy Between Evidence Based Medicine and the Real‐World Practice, Single Centre Experience

Stroke: Vascular and Interventional Neurology ◽

10.1161/svin.01.suppl_1.000068 ◽

2021 ◽

Vol 1 (S1) ◽

Author(s):

Islam El Malky ◽

Ali Hendi ◽

Hazem Abdelkhalek

Keyword(s):

Clinical Outcome ◽

Intracranial Hemorrhage ◽

Basilar Artery ◽

Real World ◽

Artery Occlusion ◽

Basilar Artery Occlusion ◽

Early Reperfusion ◽

Good Outcome ◽

Symptomatic Intracranial Hemorrhage ◽

Multiple Variables

Introduction : BAO (basilar artery occlusion) is well known by catastrophic outcomes whether death or disability in approximately 70 %. 1 Thrombectomy as an intervention in large vessel occlusion of anterior proximal circulation was approved after multiple RCTs and meta‐analyses. 2 In spite of two RCTs that appeared lately, there is still uncertainty about the effect of thrombectomy in BAO. 9, 10 Our study aims to report the outcome of BAO, as a further clue of MT effectiveness in BAO and variables affecting good outcome and mortality rate. Methods : We retrospectively collected the clinical and radiological data of 30 BAO patients treated in our center between 2016 and 2020. There is no limitation as regard age or presenting NIHHS. Twenty‐two patients who came to the emergency within 4.5 hours had I.V. thrombolytic therapy (73.3%). A favorable clinical outcome was considered if mRS ≤ 2. Angioplasty, stenting, or I.A thrombolysis were used as a rescue treatment. Symptomatic intracranial hemorrhage within two days after the initiation of treatment and mortality at 90 days were reported. The radiological outcome was assessed by modified Thrombolysis in Cerebral Infarction (mTICI) score where mTICI ≥ 2b or 3 at the end of the intervention was considered a favorable radiological result. Multiple variables were tested for their effect on favorable clinical outcomes and mortality (Table 1). Results : Among 30 patients, the mean age was 61.23 ± 16.81 years; 20/30 (66.7%) male. A favorable functional outcome was achieved in (40.7%). Successful revascularization was achieved in 26 patients (86.7 %). Four patients had procedural complications (13.3%). Symptomatic intracranial hemorrhage occurred in three cases (11%) and mortality at 90 days was 11 patients (36.7 %). The presenting NIHSS is the only predictor of mortality and the optimal cut‐off value for death was 15 with AUC = 0.758 (sensitivity 91 % and specificity 59%) and p‐value = 0.02. TOR (time of onset to recanalization) had no effect on the clinical outcome which is controversy with the paradigm of early reperfusion leading to a good outcome Conclusions : In spite of two RCSs approved no statistical difference between medical treatment and thrombectomy, thrombectomy is still an effective procedure in real‐world practice in selected cases. The presenting NIHSS is the only predictor of mortality in our studies. More studies are warranted to discover other predictors of BAO thrombectomy outcome to improve case selection and avoid futile recanalization.

Download Full-text

Abstract WP26: Improved Clinical Outcome of Acute Basilar Artery Occlusion Since Introduction of Endovascular Thrombectomy Devices

Stroke ◽

10.1161/str.44.suppl_1.awp26 ◽

2013 ◽

Vol 44 (suppl_1) ◽

Author(s):

Peter A Ringleb ◽

Lars Kellert ◽

Markus Moehlenbruch ◽

Simon Nagel ◽

Julian Boesel ◽

...

Keyword(s):

Clinical Outcome ◽

Functional Outcome ◽

Basilar Artery ◽

Treatment Strategies ◽

Artery Occlusion ◽

Basilar Artery Occlusion ◽

Good Clinical Outcome ◽

Entire Cohort ◽

Before And After ◽

Common Clinical Practice

Background: Survival and functional outcome of patients with acute basilar artery occlusion (BAO) are highly dependent on vessel recanalization. Therefore intra-arterial thrombolysis is recommended in international guidelines. For several years, thrombectomy-devices are used for intra-arterial therapy. We analyzed if the use of those devices modified the outcome of patients with BAO in our institution. Method: Retrospective analysis of prospectively collected data on consecutive patients with acute BAO since 1998. In July 2009 for the first time a thrombectomy device was used in a patient with BAO. Thereafter the cohort was split into two chronological groups. All patients were treated at a dedicated neurological ICU following institutional SOPs. Functional outcome was assessed three months after treatment using the modified Rankin Scale (mRS); good clinical outcome was defined as mRS 0-2. Symptomatic intracranial hemorrhage (sICH) was defined as intracranial blood on follow-up imaging up to 36 hours after treatment associated with clinical worsening of at least 4 points of the NIHSS or leading to death. Results: From the entire cohort of N=124 patients, n=91 patients were treated before and n=33 after July 2009. A “bridging concept” (i.e. IVT + IAT) was applied in 20% vs. 64% of the patients before and after July 2009, respectively. Complete recanalization (TICI 3) was achieved in 45% before and 77% after July 2009 (p=0.005). SICH occurred in 7% of the earlier and 3% of the later cohort (p=0.67); good clinical outcome was observed in 10% of the earlier and 33% of the later cohort (p=0.004); mortality was 57% in the earlier and 30% in the later group (p=0.01). After adjustment for baseline imbalances (proportion of patients with previous stroke, time until first treatment) the differences remained significant for good clinical outcome (OR 3.86; 95%CI 1.27 - 11.7; p=0.017) and mortality (OR 0.38; 95%CI 0.15-0.99; p=0.047). Conclusion: Modern thrombectomy-devices as well as the increased use of bridging approaches for treatment of BAO have significantly improved good clinical outcome and attenuated mortality. Especially in patients with BAO - where endovascular treatment strategies are common clinical practice - those devices should be used more frequently.

Download Full-text